Refine
Year of publication
- 2017 (155) (remove)
Institute
- Fachbereich Medizintechnik und Technomathematik (61)
- IfB - Institut für Bioengineering (32)
- INB - Institut für Nano- und Biotechnologien (26)
- Fachbereich Elektrotechnik und Informationstechnik (25)
- Fachbereich Luft- und Raumfahrttechnik (22)
- Fachbereich Energietechnik (14)
- Fachbereich Chemie und Biotechnologie (12)
- Fachbereich Maschinenbau und Mechatronik (10)
- MASKOR Institut für Mobile Autonome Systeme und Kognitive Robotik (10)
- Fachbereich Bauingenieurwesen (7)
Language
- English (155) (remove)
Document Type
- Article (72)
- Conference Proceeding (67)
- Part of a Book (12)
- Other (2)
- Book (1)
- Patent (1)
Keywords
- MASCOT (2)
- 3D nonlinear finite element model (1)
- Acceptance tests (1)
- Automated Optimization (1)
- Autonomous mobile robots (1)
- Biomolecular logic gate (1)
- CNOT (1)
- Capacitive field-effect (1)
- Chemical images (1)
- Chemical sensor (1)
Is part of the Bibliography
- no (155)
Three amperometric biosensors have been developed for the detection of L-malic acid, fumaric acid, and L -aspartic acid, all based on the combination of a malate-specific dehydrogenase (MDH, EC 1.1.1.37) and diaphorase (DIA, EC 1.8.1.4). The stepwise expansion of the malate platform with the enzymes fumarate hydratase (FH, EC 4.2.1.2) and aspartate ammonia-lyase (ASPA, EC 4.3.1.1) resulted in multi-enzyme reaction cascades and, thus, augmentation of the substrate spectrum of the sensors. Electrochemical measurements were carried out in presence of the cofactor β-nicotinamide adenine dinucleotide (NAD+) and the redox mediator hexacyanoferrate (III) (HCFIII). The amperometric detection is mediated by oxidation of hexacyanoferrate (II) (HCFII) at an applied potential of + 0.3 V vs. Ag/AgCl. For each biosensor, optimum working conditions were defined by adjustment of cofactor concentrations, buffer pH, and immobilization procedure. Under these improved conditions, amperometric responses were linear up to 3.0 mM for L-malate and fumarate, respectively, with a corresponding sensitivity of 0.7 μA mM−1 (L-malate biosensor) and 0.4 μA mM−1 (fumarate biosensor). The L-aspartate detection system displayed a linear range of 1.0–10.0 mM with a sensitivity of 0.09 μA mM−1. The sensor characteristics suggest that the developed platform provides a promising method for the detection and differentiation of the three substrates.
Genetically humanized mice for proteins involved in drug metabolism and toxicity and mice engrafted with human hepatocytes are emerging as promising in vivo models for improved prediction of the pharmacokinetic, drug–drug interaction, and safety characteristics of compounds in humans. This is an overview on the genetically humanized and chimeric liver-humanized mouse models, which are illustrated with examples of their utility in drug metabolism and toxicity studies. The models are compared to give guidance for selection of the most appropriate model by highlighting advantages and disadvantages to be carefully considered when used for studies in drug discovery and development.